{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:14:41Z","timestamp":1777493681165,"version":"3.51.4"},"reference-count":64,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The purpose of this study was to examine the impact of prior authorization policies on the receipt of antipsychotic medication for Medicaid-enrolled children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using de-identified administrative Medicaid data from two large, neighboring, mid-Atlantic states from November 2007 through June 2011, we identified subjects &lt;18 years of age using antipsychotics, from the broader group of children and adolescents receiving behavioral health services or any psychotropic medication. Prior authorization for antipsychotics was required for children in State A &lt;6 years of age from September 2008, and for children &lt;13 years of age from August 2009. No such prior authorizations existed in State B during that period. Filled prescriptions were identified in the data using national drug codes. Using a triple-difference strategy (using differences among the states, time periods, and differences in antidepressant prescribing rates among states over the same time periods), we examined the effect of the prior authorization policy on the rate at which antipsychotic prescriptions were filled for Medicaid-enrolled children and adolescents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The impact of prior authorization policies on antipsychotic medication use varied by age: Among 6\u201312 year old children, the impact of the prior authorization policy on antipsychotic medication prescribing was a modest but statistically significant decrease of 0.47% after adjusting for other factors; there was no effect of the prior authorization among children 0\u20135 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Prior authorization policies had a modest but statistically significant effect on antipsychotic use in 6\u201312 year old children, but had no impact in younger children. Future research is needed to understand the utilization and clinical effects of prior authorization and other policies and interventions designed to influence antipsychotic use in children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2014.0008","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T09:24:36Z","timestamp":1408613076000},"page":"374-381","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":30,"title":["The Effects of Prior Authorization Policies on Medicaid-Enrolled Children's Use of Antipsychotic Medications: Evidence from Two Mid-Atlantic States"],"prefix":"10.1177","volume":"24","author":[{"given":"Bradley D.","family":"Stein","sequence":"first","affiliation":[{"name":"RAND Corporation"},{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Leckman-Westin","sequence":"additional","affiliation":[{"name":"New York State Office of Mental Health"},{"name":"University at Albany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Okeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Scharf","sequence":"additional","affiliation":[{"name":"RAND Corporation"},{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sorbero","sequence":"additional","affiliation":[{"name":"RAND Corporation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxian","family":"Chen","sequence":"additional","affiliation":[{"name":"New York State Office of Mental Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka Ho Brian","family":"Chor","sequence":"additional","affiliation":[{"name":"New York University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Finnerty","sequence":"additional","affiliation":[{"name":"New York State Office of Mental Health"},{"name":"New York University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer P.","family":"Wisdom","sequence":"additional","affiliation":[{"name":"George Washington University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2009.0063"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.39"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X158075"},{"key":"e_1_3_3_5_1","first-page":"40","article-title":"Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations","volume":"40","author":"Becker ER","year":"2013","unstructured":"Becker ER, , Constantine RJ, , McPherson MA, , Jones ME: Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations. J Health Care Finance, 40:40\u201367, 2013.","journal-title":"J Health Care Finance"},{"key":"e_1_3_3_6_1","first-page":"131","volume-title":"Incentives and Choice in Health Care","author":"Berndt ER","year":"2008","unstructured":"Berndt ER, , Donohue JM: The economics of advertising in health care markets. In: Incentives and Choice in Health Care. Edited by Sloan F., and Kasper H.. Cambridge, MA: MIT Press; 2008. pp 131\u2013162."},{"key":"e_1_3_3_7_1","unstructured":"Caccavale J: Psychiatry In Crisis: Impacts on Primary Care Patient Safety and Public Healthcare Policy. I. Available at http:\/\/www.truthindrugs.org\/pdf\/crisis.pdf. Accessed May21 2014."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.10.1162"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0068"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2005.11.002"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e318040b25f"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000220851.94392.30"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1549"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.5.w770"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.3.w490"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.24.3.780"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.5.507"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.08.009"},{"issue":"4","key":"e_1_3_3_19_1","first-page":"9","article-title":"Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents","volume":"69","author":"Findling RL","year":"2008","unstructured":"Findling RL: Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. J Clin Psychiatry, 69 Suppl 4:9\u201314, 2008.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2007.58.1.135"},{"key":"e_1_3_3_21_1","unstructured":"Foti ME Harper G Moon R Oestreich G Snow R Thompson J Finnerty M Freeman E Knapp P Muse NJ Parks J Crystal S Gerhard T Wilson N: Antipsychotic Medication Use in Medicaid Children and Adolescents: Report and Resource Guide From a 16-State Study. MMDLN\/Rutgers CERTs 2010."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L015"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20120307-13"},{"key":"e_1_3_3_24_1","first-page":"9","article-title":"The Partnership Access Line: Establishing an empirically based child psychiatry consultation program for Washington State","volume":"9","author":"Hilt R","year":"2009","unstructured":"Hilt R, , McDonell MG RC, , Golombek A, , Thompson J: The Partnership Access Line: Establishing an empirically based child psychiatry consultation program for Washington State. Rep Emot Behav Disord Youth, 9:9\u201312, 2009.","journal-title":"Rep Emot Behav Disord Youth"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamapediatrics.47"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurenf.2012.04.325"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1997"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.20120p202"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ap.27.4.277"},{"key":"e_1_3_3_30_1","article-title":"Answers About Child Psychiatry","author":"Koplewicz H","year":"2010","unstructured":"Koplewicz H. Answers About Child Psychiatry. The New York Times, May 26, 2010.","journal-title":"The New York Times"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.5.540"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chiabu.2011.01.012"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008559.pub2"},{"key":"e_1_3_3_34_1","unstructured":"Manderscheid RW Henderson MJ: Mental health practitioners and trainees. In: Mental Health United States 2002. Rockville MD: United States Department of Health and Human Services (USDHHS) Substance Abuse and Mental Health Services Administration; 2002 pp. 332\u2013373."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2012.01461.x"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.162.10.929"},{"key":"e_1_3_3_37_1","first-page":"1","article-title":"Medication use in US youth with mental disorders","author":"Merikangas KR","year":"2012","unstructured":"Merikangas KR, , He J, , Rapoport J, , Vitiello B, , Olfson M: Medication use in US youth with mental disorders. Arch Pediatr Adolesc Med:1\u20138, 2012.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"e_1_3_3_38_1","unstructured":"Musgrove B. Use of antipsychotic drugs up sharply among poor children in Kentucky. I. Available at http:\/\/www.mcclatchydc.com\/2012\/10\/10\/171084\/use\u2013of-antipsychotic-drugs-up.html Accessed May21 2014."},{"key":"e_1_3_3_39_1","volume-title":"Proceedings of the 60th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"Naylor M","year":"2013","unstructured":"Naylor M: Monitoring the use of antipsychotic medications in foster children: The Illinois model. In: Proceedings of the 60th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Orlando, FL, 2013."},{"key":"e_1_3_3_40_1","first-page":"175","article-title":"Psychotropic medication management for youth in state care: Consent, oversight, and policy considerations","volume":"86","author":"Naylor MW","year":"2007","unstructured":"Naylor MW, , Davidson CV, , Ortega\u2013Piron DJ, , Bass A, , Gutierrez A, , Hall A: Psychotropic medication management for youth in state care: Consent, oversight, and policy considerations. Child Welfare, 86:175\u2013192, 2007.","journal-title":"Child Welfare"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2012.647"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.6.679"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2009.09.003"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200205000-00008"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a006913"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000189036.11725.a6"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000157543.74509.c8"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454602760386905"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2010.61.2.123"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2004.14.433"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/1077559509360916"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.433"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","unstructured":"Seida J Schouten J Mousavi S Hamm M Beaith A Vandermeer B Dryden D Boylan K Newton A: First-and second-generation antipsychotics for children and young adults. Comparative Effectiveness Review No. 39. Rockville MD: Agency for Healthcare Research and Quality; 2012.","DOI":"10.1542\/peds.2011-2158"},{"key":"e_1_3_3_54_1","first-page":"317","article-title":"Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid program","volume":"16","author":"Simeone JC","year":"2010","unstructured":"Simeone JC, , Marcoux RM, , Quilliam BJ: Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid program. J Manag Care Pharm, 16:317\u2013328, 2010.","journal-title":"J Manag Care Pharm"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.27.3.w185"},{"key":"e_1_3_3_56_1","unstructured":"Texas Health and Human Services Commission: Safety and Appropriateness of Antipsychotic Medications for Medicaid Children Under Age 16. Report to the Texas Legislature as Required by H.B. 2163 81st Legislature Regular Session 2009 2010."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.57.1.63"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000225353.16831.5d"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2010.1296"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M620"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-7610.00110"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-2-26"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1025"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.157.1.17"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0212"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2014.0008","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2014.0008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2014.0008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:56:02Z","timestamp":1777388162000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2014.0008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1089\/cap.2014.0008"],"URL":"https:\/\/doi.org\/10.1089\/cap.2014.0008","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}